Erythrocyte lipids and vitamin E in type II congenital dyserythropoietic anemia.
D000745:Anemia, Hemolytic, Congenital / Q000097:blood* / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D001856:Bone Marrow Examination; D002463:Cell Membrane Permeability / Q000187:drug effects; D002648:Child; D004912:Erythrocytes / Q000032:analysis*; D004913:Erythrocytes, Abnormal; D004920:Erythropoiesis / Q000187:drug effects*; D005260:Female; D006801:Humans; D006932:Hyperbilirubinemia / Q000150:complications; D010714:Phosphatidylethanolamines / Q000097:blood; D010743:Phospholipids / Q000097:blood*; D014810:Vitamin E / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D014811:Vitamin E Deficiency / Q000188:drug therapy
D010714:Phosphatidylethanolamines; D010743:Phospholipids; D014810:Vitamin E